353 related articles for article (PubMed ID: 26755856)
1. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.
Kestens C; Siersema PD; van Baal JW
World J Gastroenterol; 2016 Jan; 22(1):1-7. PubMed ID: 26755856
[TBL] [Abstract][Full Text] [Related]
2. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
[TBL] [Abstract][Full Text] [Related]
3. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
4. Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
Zhan C; Yan L; Wang L; Jiang W; Zhang Y; Xi J; Jin Y; Chen L; Shi Y; Lin Z; Wang Q
Dis Esophagus; 2016 Nov; 29(8):920-928. PubMed ID: 26402921
[TBL] [Abstract][Full Text] [Related]
5. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
[TBL] [Abstract][Full Text] [Related]
6. miR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP.
Xu Y; He J; Wang Y; Zhu X; Pan Q; Xie Q; Sun F
FEBS Lett; 2015 Apr; 589(10):1127-35. PubMed ID: 25841337
[TBL] [Abstract][Full Text] [Related]
7. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
[TBL] [Abstract][Full Text] [Related]
8. [Role of miRNA in the diagnosis, prognosis and treatment of esophageal cancer].
Cao XF; Li SQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):161-4. PubMed ID: 21575511
[No Abstract] [Full Text] [Related]
9. MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma.
Nohata N; Hanazawa T; Kinoshita T; Okamoto Y; Seki N
Auris Nasus Larynx; 2013 Apr; 40(2):143-9. PubMed ID: 22831895
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression and function in cancer.
Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.
Huang J; Zhang SY; Gao YM; Liu YF; Liu YB; Zhao ZG; Yang K
Cell Prolif; 2014 Aug; 47(4):277-86. PubMed ID: 24909356
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy.
Ko MA; Zehong G; Virtanen C; Guindi M; Waddell TK; Keshavjee S; Darling GE
Ann Thorac Surg; 2012 Oct; 94(4):1094-102; discussion 1102-3. PubMed ID: 22939244
[TBL] [Abstract][Full Text] [Related]
13. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2.
Wang Z; Qiao Q; Chen M; Li X; Wang Z; Liu C; Xie Z
FEBS Lett; 2014 Mar; 588(6):915-21. PubMed ID: 24508466
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer.
Winther M; Alsner J; Sørensen BS; Wittrup CF; Tramm T; Baeksgaard L; Hofland K; Holtved E; Nordsmark M
Anticancer Res; 2016 Feb; 36(2):721-30. PubMed ID: 26851030
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA function in cancer: oncogene or a tumor suppressor?
Shenouda SK; Alahari SK
Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
[TBL] [Abstract][Full Text] [Related]
16. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy.
Malhotra A; Sharma U; Puhan S; Chandra Bandari N; Kharb A; Arifa PP; Thakur L; Prakash H; Vasquez KM; Jain A
Biochimie; 2019 Jan; 156():148-157. PubMed ID: 30326253
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
19. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in esophageal cancer (review).
He B; Yin B; Wang B; Xia Z; Chen C; Tang J
Mol Med Rep; 2012 Sep; 6(3):459-65. PubMed ID: 22751839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
